A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
Clinical trial NCT04072900 · UNKNOWN
Trial details
- NCT number
- NCT04072900
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-21
- Primary completion
- 2021-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.